Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50

Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, is confident in being able to secure all necessary outstanding regulatory and antitrust approvals in connection with its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash.

Thermo Fisher expects to consummate the tender offer promptly after its expiration, scheduled for 7:00 p.m., New York City time, on Friday, May 13, 2011, subject to receipt of these approvals. Consummation of the tender offer also assumes that at least a majority of the outstanding shares of Dionex common stock, on a fully diluted basis, have been tendered and not withdrawn prior to the expiration of the offer and that other standard closing conditions have been satisfied.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 18). Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50. News-Medical. Retrieved on April 17, 2024 from https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50". News-Medical. 17 April 2024. <https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50". News-Medical. https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx. (accessed April 17, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific to acquire all outstanding shares of Dionex for $118.50. News-Medical, viewed 17 April 2024, https://www.news-medical.net/news/20110511/Thermo-Fisher-Scientific-to-acquire-all-outstanding-shares-of-Dionex-for-2411850.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies